These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5310375)

  • 1. Chlorpromazine-induced antinuclear factors.
    Berglund S; Gottfries CG; Gottfries I; Stormby K
    Acta Med Scand; 1970; 187(1-2):67-74. PubMed ID: 5310375
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear factors in relation to age, sex, mental disease and treatment with phenothiazines.
    Gottfries CG; Gottfries I
    Acta Psychiatr Scand Suppl; 1974; 255():193-201. PubMed ID: 4156897
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
    Gallien M; Schnetzler JP; Morin J
    Ann Med Psychol (Paris); 1975 Feb; 1(2):237-48. PubMed ID: 9021
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehesiven clinical studies with thiothixene.
    Ban TA; Lehmann HE; Sterlin C; Climan M
    Dis Nerv Syst; 1975 Sep; 36(9):473-7. PubMed ID: 240651
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
    Douglas KW; Hindley JP
    J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma level of cyclic AMP and mental diseases.
    Erban L; Prokes J; Richtrová E
    Act Nerv Super (Praha); 1980 Dec; 22(4):269-73. PubMed ID: 6259868
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic specificity of chlorpromazine-induced antinuclear antibodies.
    Alarcón-Segovia D; Fishbein E; Cetina JA; Raya RJ; Barrera E
    Clin Exp Immunol; 1973 Dec; 15(4):543-8. PubMed ID: 4130538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of mode of management on plasma chlorpromazine in psychiatric patients.
    Rivera-Calimlim L; Castañeda L; Lasagna L
    Clin Pharmacol Ther; 1973; 14(6):978-86. PubMed ID: 4584156
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proketazine in the treatment of psychotic syndromes].
    Klosińska B; Wierzbicki T
    Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses.
    Smith AG; Goolamali SK; Thody AJ; Shuster S; Pye RJ; Burton JL
    Br J Dermatol; 1977 May; 96(5):537-9. PubMed ID: 871390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-Bw44 with chlorpromazine-induced autoantibodies.
    Canoso RT; Lewis ME; Yunis EJ
    Clin Immunol Immunopathol; 1982 Nov; 25(2):278-82. PubMed ID: 6819913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of the combination of propericiazine with chlorpromazine in the psychiatric field].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1965 Dec; 123(5):655-64. PubMed ID: 4379140
    [No Abstract]   [Full Text] [Related]  

  • 15. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.
    Johnstone EC; Whaley K
    Br Med J; 1975 Jun; 2(5973):724-5. PubMed ID: 1079738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of propericiazine and chlorpromazine in "behaviour disorders".
    Rajotte P; Giard N; Tétreault L
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):166-74. PubMed ID: 4379671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications for the use of neuleptil. Review of the literature and clinical contribution].
    Catalano A; Del Pistoia L; De Risio C; Ridolo P
    Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulins in psychiatric patients.
    Solomon GF; Allansmith M; McCellan B; Amkraut A
    Arch Gen Psychiatry; 1969 Mar; 20(3):272-7. PubMed ID: 4974471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.